Navigation Links
Allscripts Announces Second Quarter 2012 Results
Date:8/8/2012

ase refer to Table 4 "Condensed Non-GAAP Financial Information" for a complete reconciliation of all GAAP and non-GAAP financial measures discussed in this press release. 

"Our second-quarter results were solid and demonstrated improvement in several key business metrics," said Glen Tullman, Chief Executive Officer of Allscripts.  "We signed two new Sunrise Clinical Manager (SCM) clients in the quarter plus one SCM footprint expansion within the client base.  In addition, ambulatory bookings increased quarter-over-quarter, further expanding Allscripts market reach.  We also generated solid operating cash flow of close to $60 million."We are aggressively focused on executing our business plan and delivering on our client commitments.  We remain on schedule to release important new solution enhancements during the fourth quarter of 2012.  Allscripts remains well positioned in a robust market with a comprehensive portfolio spanning the ambulatory, acute and post-acute care delivery environments."

Stock Repurchase Program and Credit FacilitiesIn April 2012 the Allscripts Board of Directors approved a $200 million increase in the Company's existing stock repurchase program increasing the total repurchase authorization to $400 million.During the three months ended June 30, 2012, Allscripts repurchased approximately 21 million shares of common stock for approximately $225 million at an average price of approximately $10.87 per share.  As of June 30, 2012, the amount available for repurchase of common stock under this program was approximately $123 million.

Any common stock repurchases may be made through open market transactions, block trades, privately negotiated transactions (including accelerated share repurchase transactions) or other means. Any repurchase activity will depend on factors such as the Company's working capital needs, cash requirements for investments, debt repayment obligations, the Company's stock
'/>"/>

SOURCE Allscripts Healthcare Solutions, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. Allscripts Adds Two Independent Directors to Board
2. Developers: Deadline Approaching for Allscripts Million Hearts CDS Challenge
3. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
4. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
5. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
6. Misonix Announces New Distribution Agreement For Panama
7. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
8. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
9. Boston Scientific Announces CE Mark and European Launch of Emerge™ PTCA Dilatation Catheter
10. Soligenix Announces Further Progress with ThermoVax™ for Long-Term Vaccine ThermoStability
11. Masimo Announces New Low-Profile Infant and Neonatal Pulse Oximetry Sensors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... -- With the heroin epidemic in the United ... -based Lakeview Health drug and alcohol treatment center,s ... why fentanyl is causing a new wave of overdoses. ... potent than pharmaceutical grade heroin and often illegally purchased ... death skyrockets. "Fentanyl can be an important ...
(Date:8/28/2015)... 28, 2015 Research and ... the "Investigation Report on China,s Bevacizumab Market ,2010-2019" ... Roche under the trade name of Avastin, bevacizumab injection ... Feb.26, 2010, it was approved by CFDA to treat ... China all come from Roche and ...
(Date:8/28/2015)... 2015 Research and ... of the "Investigation Report on China,s Quetiapine ... Developed by AstraZeneca plc, quetiapine (under the ... for the treatment of schizophrenia. Approved by CFDA ... in the Catalogue of Drugs for the Basic ...
Breaking Medicine Technology:Lakeview Health's Dr. Philip Hemphill Explains Why Heroin Addicts Are Now Dying of Fentanyl Overdoses 2Investigation Report on China's Bevacizumab Market 2015-2019 2China Quetiapine Market Investigation Report 2010-2019 2
... (Nasdaq: THOR ), a world leader in device-based ... hearts, today announced that it will report its operating results ... 1. The company will hold a conference call ... all interested parties, at 1:30 p.m., Pacific Daylight Time (4:30 ...
... 2011 At the 5 ... in Barcelona, Spain (20-22 October 2011),   Merz Pharmaceuticals ... efficacy and safety of   XEOMIN ® ... Dystonia is a particularly debilitating condition ...
Cached Medicine Technology:Thoratec Schedules Third Quarter Conference Call, Webcast 2Merz research Shows Long-term Benefits for Patients With Dystonia 2Merz research Shows Long-term Benefits for Patients With Dystonia 3Merz research Shows Long-term Benefits for Patients With Dystonia 4
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... ... AdvantaClean franchise business with a ribbon-cutting ceremony on Aug. 26, generously hosted by ... and booking inspection appointments via AdvantaClean’s National Call Center and website since Aug. ...
(Date:8/31/2015)... ... , ... Finnleo is pleased to announce another in a long ... extensive engineering and design of our newest sauna model, the Terrace combines high quality ... at a very attractive price-point. , Before outdoor saunas were a dream for ...
(Date:8/31/2015)... ... August 31, 2015 , ... Finnleo , a leader ... Available starting in the 3rd quarter, the newly re-styled and re-designed “Hallmark Series” updates ... tools. , These new models include more glass and a more upscale feel than ...
(Date:8/31/2015)... ... August 31, 2015 , ... ... professor Luciana Lagana (aka Dr. Luciana) received a total of three Silver ... Best Documentary, and Best (Dis)ability Film. Dr. Luciana co-wrote and co-produced this pilot ...
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... ... provider of the CME-certified annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for ... be held Nov. 4 – 6 in New York City. The annual legacy ...
Breaking Medicine News(10 mins):Health News:Ribbon Cutting Launches AdvantaClean of Madison County 2Health News:Say “Hello” to the Brand New Finnleo Terrace Outdoor Saunas 2Health News:Finnleo Introduces Hallmark Series Saunas 2Health News:Actor/Writer/Director/Psychology Professor Luciana Lagana Receives Three Wins at the 2015 Global Independent Film Awards for the TV Pilot Dr. Luciana on Aging and Falling 2Health News:Physicians’ Education Resource® Seeks Abstracts for the Upcoming Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® 2Health News:Physicians’ Education Resource® Seeks Abstracts for the Upcoming Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® 3Health News:Physicians’ Education Resource® Seeks Abstracts for the Upcoming Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® 4
... awareness of maritime pollution and secure a place in history ... Pacific Ocean from San Francisco on Thursday. ... her lightweight 24-foot (seven meter) silver rowing boat and is ... trek across the vast expanse of the Pacific. ...
... Trump has confirmed that she is set to marry her ... ,However, the confirmation will come as a surprise to her ... ,The ex-wife of Donald Trump revealed her plans to become ... she writes a weekly advice column. ,The 58-year-old ...
... she often surfs porn websites, for she believes that it ... ,The estranged wife of rocker Marilyn Manson feels that ... ,"Amateur pornography is a great thing. You can find ... saying. ,She insists that she is just like ...
... involved in some of the highest-profile health scares involving ... product safety, a top official said Friday. ... fundamental problems behind issues relating to food product safety," ... top product safety agency told a news conference. ...
... 20 million pounds to his estranged wife Heather Mills in ... million pounds, if reports are to be believed. ... in the range of somewhere between 25 to 30 million ... ,However, their stubbornness is now indicating that they ...
... Indian Council of Medical Research Director-General N. K. Ganguly on ... trials conducted in India would be registered. These trials ... ,The national registry will make the trails more transparent. It ... researcher who plans to conduct drug trials on humans is ...
Cached Medicine News:Health News:Briton Set for Pacific Solo Odyssey to Highlight Warming 2Health News:China Vows to Improve Food Safety in Wake of Health Scares 2Health News:Clinical Trials Registry Launched in India 2
Intended for the quantitative determination of aspartate aminotransferase activity in serum or plasma. Reaction: Kinetic. Wavelength: 340 nm. Linearity: 268 U/L at 30C. Two vials, dry powder reagents...
For the quantitative determination of aspartate aminotransferase in serum. Optimized IFCC procedure without P-5'-P. 500 IU/L at 37C linearity....
The Definitive automated slide stainer is an industry standard. The Definitive allows automated slide staining in a compact, self-contained and easy-to use package....
... an "assembly-line worker" for routine staining protocols ... Programmable continuous slide stainer for routine stains. ... in short time. Its large number of ... working principle provides a high throughput. A ...
Medicine Products: